100 related articles for article (PubMed ID: 29086895)
1. Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant.
Peghin M; Maiani M; Castaldo N; Givone F; Righi E; Lechiancole A; Sartor A; Pea F; Livi U; Bassetti M
Infection; 2018 Apr; 46(2):263-265. PubMed ID: 29086895
[TBL] [Abstract][Full Text] [Related]
2.
Aslam S; Roach D; Nikolich MP; Biswas B; Schooley RT; Lilly-Bishop KA; Rice GK; Cer RZ; Hamilton T; Henry M; Luong T; Salabarria A-C; Sisk-Hackworth L; Filippov AA; Lebreton F; Hall L; Nir-Paz R; Onallah H; Livni G; Shostak E; Wieder-Finesod A; Yahav D; Yerushalmy O; Alkalay-Oren S; Braunstein R; Khalifa L; Rimon A; Gelman D; Hazan R
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0172823. PubMed ID: 38470133
[TBL] [Abstract][Full Text] [Related]
3. Identification, prioritization, and evaluation of RlpA protein as a target against multidrug-resistant Pseudomonas aeruginosa.
Gatasheh MK; Murugan N; Krishnamoorthy R; Alshuniaber MA; Malathi J; Umashankar V; Ramalingam G; Veeraraghavan VP; Jayaraman S
Acta Trop; 2024 Jul; 255():107216. PubMed ID: 38636584
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of treatment for deep left ventricular assist device infection.
Simpson MT; Ning Y; Kurlansky P; Colombo PC; Yuzefpolskaya M; Uriel N; Naka Y; Takeda K
J Thorac Cardiovasc Surg; 2024 May; 167(5):1824-1832.e2. PubMed ID: 36280430
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Pseudomonas aeruginosa and its antibiotic resistance in patients who have received Hematopoietic Stem-Cell Transplantation; A globally Systematic Review.
Shakerimoghaddam A; Moghaddam AD; Barghchi B; Pisheh Sanani MG; Azami P; Kalmishi A; Sabeghi P; Motavalli F; Khomartash MS; Mousavi SH; Nikmanesh Y
Microb Pathog; 2023 Nov; 184():106368. PubMed ID: 37769854
[TBL] [Abstract][Full Text] [Related]
6. Liposomal Formulation Reduces Transport and Cell Uptake of Colistin in Human Lung Epithelial Calu-3 Cell and 3D Human Lung Primary Tissue Models.
Huang Y; Yu S; Ahmed MU; Zhou QT
AAPS PharmSciTech; 2024 Feb; 25(3):40. PubMed ID: 38366100
[TBL] [Abstract][Full Text] [Related]
7. Methodological Issues in a Retrospective Study on Short-course Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections in China.
Okumura N; Yamada G; Yamamoto K; Tsuzuki S
Clin Infect Dis; 2024 Mar; ():. PubMed ID: 38500404
[No Abstract] [Full Text] [Related]
8. The study design and methodology of antibiotic duration in hematological patients with pseudomonas aeruginosa bloodstream infection.
Feng X; Qian C; Fan Y; Li J; Wang J; Lin Q; Jiang E; Mi Y; Qiu L; Xiao Z; Wang J; Hong M; Feng S
Clin Infect Dis; 2024 May; ():. PubMed ID: 38807461
[No Abstract] [Full Text] [Related]
9. Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.
Fraile-Ribot PA; Cabot G; Mulet X; Periañez L; Martín-Pena ML; Juan C; Pérez JL; Oliver A
J Antimicrob Chemother; 2018 Mar; 73(3):658-663. PubMed ID: 29149337
[TBL] [Abstract][Full Text] [Related]
10. Ceftolozane/tazobactam activity against meropenem-non-susceptible Pseudomonas aeruginosa bloodstream infection isolates.
Skoglund E; Ledesma KR; Lasco TM; Tam VH
J Glob Antimicrob Resist; 2017 Dec; 11():154-155. PubMed ID: 29101084
[No Abstract] [Full Text] [Related]
11. Determination of alternative ceftolozane/tazobactam dosing regimens for patients with infections due to Pseudomonas aeruginosa with MIC values between 4 and 32 mg/L.
Natesan S; Pai MP; Lodise TP
J Antimicrob Chemother; 2017 Oct; 72(10):2813-2816. PubMed ID: 29091209
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States.
Prabhu VS; Solomkin JS; Medic G; Foo J; Borse RH; Kauf T; Miller B; Sen SS; Basu A
Antimicrob Resist Infect Control; 2017; 6():107. PubMed ID: 29090091
[TBL] [Abstract][Full Text] [Related]
13. The emergence of multidrug-resistant
AbdulWahab A; Zahraldin K; Sid Ahmed MA; Jarir SA; Muneer M; Mohamed SF; Hamid JM; Hassan AAI; Ibrahim EB
Lung India; 2017; 34(6):527-531. PubMed ID: 29098998
[TBL] [Abstract][Full Text] [Related]
14. Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates.
Denervaud-Tendon V; Poirel L; Connolly LE; Krause KM; Nordmann P
J Antimicrob Chemother; 2017 Oct; 72(10):2787-2791. PubMed ID: 29091226
[TBL] [Abstract][Full Text] [Related]
15. New antibiotics for ventilator-associated pneumonia.
Bassetti M; Vena A; Castaldo N; Righi E; Peghin M
Curr Opin Infect Dis; 2018 Apr; 31(2):177-186. PubMed ID: 29337703
[TBL] [Abstract][Full Text] [Related]
16. Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing
Mandal A; Sengupta A; Kumar A; Singh UK; Jaiswal AK; Das P; Das S
Infect Dis (Auckl); 2017; 10():1178633617739018. PubMed ID: 29151781
[TBL] [Abstract][Full Text] [Related]
17. Assessment of multiple cytochrome P450 activities in metabolically inactivated human liver microsomes and roles of P450 2C isoforms in reaction phenotyping studies.
Murayama N; Yajima K; Hikawa M; Shimura K; Ishii Y; Takada M; Uno Y; Utoh M; Iwasaki K; Yamazaki H
Biopharm Drug Dispos; 2018 Feb; 39(2):116-121. PubMed ID: 29136681
[TBL] [Abstract][Full Text] [Related]
18. Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis.
Tickell KD; Brander RL; Atlas HE; Pernica JM; Walson JL; Pavlinac PB
Lancet Glob Health; 2017 Dec; 5(12):e1235-e1248. PubMed ID: 29132613
[TBL] [Abstract][Full Text] [Related]
19. Diarrheagenic Escherichia coli and Shigella with High Rate of Extended-Spectrum Beta-Lactamase Production: Two Predominant Etiological Agents of Acute Diarrhea in Shiraz, Iran.
Aminshahidi M; Arastehfar A; Pouladfar G; Arman E; Fani F
Microb Drug Resist; 2017 Dec; 23(8):1037-1044. PubMed ID: 29106325
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, risk factors and antimicrobial resistance of Salmonella diarrhoeal infection among children in Thi-Qar Governorate, Iraq.
Harb A; O'Dea M; Hanan ZK; Abraham S; Habib I
Epidemiol Infect; 2017 Dec; 145(16):3486-3496. PubMed ID: 29103396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
